Evidence map›Paper›PMID 19836308›Full record

ReviewTrends in immunology2010

Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

Eléonore Beurel, Suzanne M Michalek, Richard S Jope

Open access · greenAbstract readReview
In one paragraph

Review in Trends in immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 221 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
221citing papers in PubMed, 2 pooled it
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

221 citing papers in PubMed, 2 syntheses or guidelines pooled it, 379 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Journal of pharmacopuncture · 2024
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

161 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eléonore BeurelDepartment of Psychiatry, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
Suzanne M Michalek
Richard S Jope
University of Alabama at Birmingham · US

Funding

LITHIUM EFFECTS ON CHOLINERGIC ACTIVITYR01MH038752 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI JOPE, RICHARD S. · 1985 to 2015
$4.4M
Genetically Engineered Oral Vaccines &Caries ImmunityR01DE009081 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHALEK, SUZANNE M. · 1990 to 2012
$3.2M
Effects of lithium on cellular signalingR56MH038752 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JOPE, RICHARD S. · 2011 to 2011
$366k
NIDCR NIH HHS DE09081NIDCR NIH HHS R01 DE009081NIMH NIH HHS MH38752NIMH NIH HHS R01 MH038752NIMH NIH HHS R56 MH038752
6 · The paper itself

Abstract

In just a few years, the view of glycogen synthase kinase-3 (GSK3) has been transformed from an obscure enzyme seldom encountered in the immune literature to one implicated in an improbably large number of roles. GSK3 is a crucial regulator of the balance between pro- and anti-inflammatory cytokine production in both the periphery and the central nervous system, so that GSK3 inhibitors such as lithium can diminish inflammation. GSK3 influences T-cell proliferation, differentiation and survival. Many effects stem from GSK3 regulation of critical transcription factors, such as NF-kappaB, NFAT and STATs. These discoveries led to the rapid application of GSK3 inhibitors to animal models of sepsis, arthritis, colitis, multiple sclerosis and others, demonstrating their potential for therapeutic intervention.

Indexed as

Adaptive ImmunityImmunity, InnateAnimalsGlycogen Synthase Kinase 3HumansLithiumSignal TransductionGlycogen Synthase Kinase 3Lithium

Identifiers

PMID19836308
PMCPMC2818223
OpenAlexW2051110479

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.